Advertisement

Delirium: Risk Factors, Contributors, Identification, Work-Up, and Treatment

  • Timothy LauEmail author
  • Elizabeth Kozyra
  • Catherine Cheng
Chapter

Abstract

Delirium is a common, serious, and life-threatening condition that is often missed and poorly managed. Increasing evidence argues that health-care providers need to assess the mental status of the patient as the “sixth vital sign.” Although functional neuroimaging and CSF biomarkers are being studied in delirium management, the diagnosis is a clinical one without a laboratory test or imaging to confirm it.

Delirium is associated with increased morbidity, mortality, slower rate of recovery, poor functional and cognitive recovery, decreased quality of life, hospital-acquired complications, placement in specialized intermediate and long-term care facilities, increased cost of care, and prolonged hospital stays. Management includes the rapid identification of the cause(s), and correcting it/them if possible. Managing risk factors such as dehydration, infection, polypharmacy, immobility, restraints, and sensory impairment is key in both identifying the cause and reducing the consequences and optimizing patient care. This chapter will explore the identification, work-up, risk factors, and management of this important condition.

Keywords

Delirium Confusion Geriatric inpatient 

References

  1. 1.
    Downing LJ, Caprio TV, Lyness JM. Geriatric psychiatry review: differential diagnosis and treatment of the 3 D’s – delirium, dementia, and depression. Curr Psychiatry Rep. 2013;15:365.Google Scholar
  2. 2.
    Leonard M, McInerney S, McFarland J, Condon C, Awan F, O’Connor M, et al. Comparison of cognitive and neuropsychiatric profiles in hospitalised elderly medical patients with delirium, dementia and comorbid delirium–dementia. BMJ Open. 2016;6(3):e009212.CrossRefGoogle Scholar
  3. 3.
    O’Sullivan R, Inouye SK, Meagher D. Delirium and depression: inter-relationship and overlap in elderly people. Lancet Psychiatry. 2014;1(4):303–11.Google Scholar
  4. 4.
    Hosker C, Ward D. Hypoactive delirium. BMJ. 2017;357:j2047.Google Scholar
  5. 5.
    Elie M, Rousseau F, Cole M, Primeau F, Mccusker J, Bellavance F. Prevalence and detection of delirium in elderly emergency department patients. CMAJ (Canadian Medical Association Journal = Journal De L’Association Medicale Canadienne). 2000;163(8):977–81.Google Scholar
  6. 6.
    Inouye SK, Westendorp RGJ, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911–22.CrossRefGoogle Scholar
  7. 7.
    Inouye SK, Marcantonio ER, Metzger ED. Doing damage in delirium: the hazards of antipsychotic treatment in elderly persons. Lancet Psychiatry. 2014;1(4):312–5.Google Scholar
  8. 8.
    Collier R. Hospital-induced delirium hits hard. CMAJ. 2012;184(1):23–4.CrossRefGoogle Scholar
  9. 9.
    Flaherty J, Rudolph J, Shay K, Kamholz B, Boockvar K, Shaughnessy M, et al. Delirium is a serious and under-recognized problem: why assessment of mental status should be the sixth vital sign. J Am Med Dir Assoc. 2007;8(5):273–5.CrossRefGoogle Scholar
  10. 10.
    Oldham MA, Flaherty JH, Maldonado JR. Refining delirium: a transtheoretical model of delirium disorder with preliminary neurophysiologic subtypes. Am J Geriatr Psychiatry. 2018;26(9):913–24.CrossRefGoogle Scholar
  11. 11.
    Witlox J, Eurelings LSM, De Jonghe JFM, Kalisvaart KJ, Eikelenboom P, Van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia. (Clinical report). JAMA. 2010;304(4):443–51.CrossRefGoogle Scholar
  12. 12.
    Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012;367(1):30–9.CrossRefGoogle Scholar
  13. 13.
    Inouye SK, Marcantonio ER, Kosar CM, Tommet D, Schmitt EM, Travison TG, et al. The short-term and long-term relationship between delirium and cognitive trajectory in older surgical patients. Alzheimers Dement. 2016;12(7):766–75.CrossRefGoogle Scholar
  14. 14.
    Reynish E, Hapca S, De Souza N, Cvoro V, Donnan P, Guthrie B. Epidemiology and outcomes of people with dementia, delirium, and unspecified cognitive impairment in the general hospital: prospective cohort study of 10,014 admissions. BMC Med. 2017;15(1):140.CrossRefGoogle Scholar
  15. 15.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington, VA, US: American Psychiatric Publishing, 2013.Google Scholar
  16. 16.
    Grover S, Kate N. Assessment scales for delirium: a review. World J Psychiatry. 2012;2(4):58–70.CrossRefGoogle Scholar
  17. 17.
    Vasunilashorn SM, Ngo L, Kosar CM, Fong TG, Jones RN, Inouye SK, Marcantonio ER. Does apolipoprotein E genotype increase risk of postoperative delirium? Am J Geriatr Psychiatry. 2015;23(10):1029–37.CrossRefGoogle Scholar
  18. 18.
    Cavallari M, Dai W, Guttmann C, Meier D, Ngo L, Hshieh T, et al. Neural substrates of vulnerability to postsurgical delirium as revealed by presurgical diffusion MRI. Brain. 2016;139(4):1282–94.CrossRefGoogle Scholar
  19. 19.
    Rockwood K. Causes of delirium. Psychiatry. 2008;7(1):39–41.CrossRefGoogle Scholar
  20. 20.
    Marcantonio ER. Delirium in hospitalized older adults. N Engl J Med. 2017;377:1456–66.CrossRefGoogle Scholar
  21. 21.
    Magny E, Le Petitcorps H, Pociumban M, Bouksani-Kacher Z, Pautas E, Belmin J, Lafuente-Lafuente C. Predisposing and precipitating factors for delirium in community-dwelling older adults admitted to hospital with this condition: a prospective case series. PLoS One. 2018;13(2):E0193034.CrossRefGoogle Scholar
  22. 22.
    Clegg A, Young J. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing. 2011;40(1):23–9.CrossRefGoogle Scholar
  23. 23.
    Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, CitAD Research Group. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014;311(7):682–91.CrossRefGoogle Scholar
  24. 24.
    Gross P. Clinical management of SIADH. Ther Adv Endocrinol Metabol. 2012;3(2):61–73.CrossRefGoogle Scholar
  25. 25.
    Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635–42.CrossRefGoogle Scholar
  26. 26.
    Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112–20.CrossRefGoogle Scholar
  27. 27.
    Oruch R, Pryme IF, Engelsen B, Lund A. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatr Dis Treat. 2017;13:161.CrossRefGoogle Scholar
  28. 28.
    Ballard C, Margallo-Lana M, Juszczak E, Douglas S, Swann A, Thomas A, et al. Quetiapine and rivastigmine and cognitive decline on Alzheimer’s disease: randomized double blind placebo controlled trial. Br Med J. 2005;330(7496):874–7.CrossRefGoogle Scholar
  29. 29.
    Schuckit MA. Recognition and management of withdrawal delirium (Delirium Tremens). N Engl J Med. 2014;371(22):2109–13.CrossRefGoogle Scholar
  30. 30.
    Anderson BJ, Reilly JP, Shashaty MG, Palakshappa JA, Wysoczanski A, Dunn TG, et al. Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis. J Crit Care. 2016;36:18–23.CrossRefGoogle Scholar
  31. 31.
    Young J, Murthy L, Westby M, Akunne A, O’Mahony R. Diagnosis, prevention, and management of delirium: summary of NICE guidance. Br Med J. 2010;28(341):c3704CrossRefGoogle Scholar
  32. 32.
    Zaubler T, Murphy K, Rizzuto L, Santos R, Skotzko C, Giordano J, Bustami R, Inouye SK. Quality improvement and cost savings with multicomponent delirium interventions: replication of the Hospital Elder Life Program in a community hospital. Psychosomatics. 2013;54(3):219–26.CrossRefGoogle Scholar
  33. 33.
    Inouye SK, Bogardus ST Jr, Baker DI, Leo-Summers L, Cooney LM Jr. The Hospital Elder Life Program: a model of care to prevent cognitive and functional decline in older hospitalized patients. J Am Geriatr Soc. 2000;48(12):1697–706.CrossRefGoogle Scholar
  34. 34.
    Hshieh TT, Yang T, Gartaganis SL, Jirong Yue J, Inouye SK. Hospital elder life program: systematic review and meta-analysis of effectiveness. Am J Geriatr Psychiatry. 2018;26(10):1015–33.CrossRefGoogle Scholar
  35. 35.
    Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry. 1996;153(2):231–7.CrossRefGoogle Scholar
  36. 36.
    Boettger S, Jenewein J, Breitbart W. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: a comparison of efficacy, safety, and side effects. Palliat Support Care. 2015;13(4):1079–85.CrossRefGoogle Scholar
  37. 37.
    Girard TD, Exline MC, Carson SS, et al. Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med. 2018;379(26):2506–16.Google Scholar
  38. 38.
    American Geriatrics Society Abstracted Clinical Practice Guideline for Postoperative Delirium in Older Adults. J Am Geriatr Soc. 2015;63(1):142–50.CrossRefGoogle Scholar
  39. 39.
    Neufeld KJ, Yue J, Robinson TN, Inouye SK, Needham DM. Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2016;64(4):705–14.CrossRefGoogle Scholar
  40. 40.
    Mu JL, Lee AM, Joynt G. Pharmacologic agents for the prevention and treatment of delirium in patients undergoing cardiac surgery: systematic review and metaanalysis. Crit Care Med. 2015;43(1):194–204.CrossRefGoogle Scholar
  41. 41.
    Cole M, Ciampi A, Belzile E, Zhong L. Persistent delirium in older hospital patients: a systematic review of frequency and prognosis. Age Ageing. 2009;38(1):19–26.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Timothy Lau
    • 1
    Email author
  • Elizabeth Kozyra
    • 2
  • Catherine Cheng
    • 3
    • 4
  1. 1.Faculty of Medicine, University of Ottawa, Department of Psychiatry, Geriatric Psychiatry Inpatient Unit, The RoyalOttawaCanada
  2. 2.Memorial University School of PharmacyOttawaCanada
  3. 3.Department of PsychiatryUniversity of AlbertaEdmontonCanada
  4. 4.Department of PsychiatryUniversity of TorontoTorontoCanada

Personalised recommendations